String Metaverse534535Routine director change
Dr. Sethurathnam Ravi to be associated as Director Emeritus in honorary, advisory capacity
String Metaverse Ltd has told BSE that Dr. Sethurathnam Ravi will be associated with it as Director Emeritus in an honorary, advisory capacity from 20 October 2026.
By ScoutQuest · · 1 min read
- Designation
- Director Emeritus
- Effective Date
- 20 October 2026
- Experience
- over 37 years of board-level experience
What was announced
- Dr. Sethurathnam Ravi will be associated with the company as Director Emeritus with effect from 20 October 2026.
- The company describes the association as honorary and advisory in nature.
- The stated purpose is that his association is expected to provide professional insights and strategic guidance in furtherance of the company's long-term business objectives.
Who is Dr. Ravi
- A Fellow Chartered Accountant with a Doctorate in Finance and Commerce.
- Over 37 years of board-level experience across banking, financial services and capital markets.
- He has served as Chairman of BSE Limited and of UTI Trustee Company Private Limited, and has held board positions at several other institutions.
- He is the Founder of Ravi Rajan & Co. LLP, with expertise in corporate governance, audit, risk management, mergers and acquisitions, valuation and corporate restructuring.
What the update records
- Name: Dr. Sethurathnam Ravi.
- Designation: Director Emeritus.
- Nature of association: honorary and advisory capacity.
- Effective date: 20 October 2026.
- Disclosure of relationships with directors: Not Applicable.
How a retail reader might see it
- The disclosure is about a person's association with the company in an advisory role, and sets out his professional background.
- The role is described as honorary and advisory, and the company links it to guidance on its long-term business objectives.
- The update does not set out any financial terms, targets or timelines linked to the association.
Also from String Metaverse
EGM held; preferential issue of up to 8,32,03,383 shares at ₹8.85 each placed for approval
15 Oct 2026
BSE grants in-principle approval for preferential issue of 8,32,03,383 shares to non-promoters
14 Oct 2026
Chairman & Non-Executive Non-Independent Director Resigns from Board
30 Sep 2026
More numbers
- Board-level experience of Dr. Sethurathnam Raviover 37 years
Source: BSE · 20 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.